Sanofi and Merck & Co end vaccines partnership


Sanofi Pasteur and Merck & Co (MSD) plan to end their joint European vaccines business and consolidate its assets within their respective companies by the end of the year. The pair originally joined forces in 1994, forming Sanofi Pasteur MSD, to develop and commercialise vaccines from both companies.

‘After carefully considering our individual strategic priorities, alongside the economic and regulatory environments for vaccine operations in the EU, we have mutually agreed that it is in our best interests to manage our vaccine product portfolios independently. We believe that focusing our efforts on opportunities unique to our respective companies will better position us to drive growth, execute in a more efficient manner and optimise vaccine coverage,’ Sanofi and MSD said in a joint statement.


Related Content

Mexico approves world’s first dengue vaccine

21 December 2015 Business

news image

Sanofi's vaccine protects children and adults against the mosquito-borne disease

10 years ago: Sanofi-Aventis takeover

30 May 2014 Flashback

news image

Aventis accepted a takeover bid from French rival Sanofi Synthélabo, creating the world's third largest pharma giant

Most Commented

WHO clarifies glyphosate risks

23 May 2016 Business

news image

UN and WHO panel conclude the herbicide glyphosate is ‘unlikely’ to cause cancer at realistic exposure levels

Large HIV vaccine trial to launch in South Africa

24 May 2016 News and Analysis

news image

US funding agency will enlist 5400 people for HIV vaccine study in South Africa in November